Pharmaceutical 3498 articles

Beasley Allen has one of the largest and most technologically advanced Mass Torts practices in the country. The Mass Torts division represents numerous people in claims against companies that manufacture and/or market defective pharmaceuticals and/or medical devices. The resources devoted to this division allow the firm to competently and conscientiously handle any group of cases, no matter how large, along with particular catastrophic injury cases.

Our firm was recently involved in one of the greatest victories in Mass Torts history, against drug manufacturer Merck regarding the drug Vioxx. After more than five years of hard-fought and difficult litigation, Merck agreed to pay $4.85 billion, the largest pharmaceutical settlement in U.S. history, to resolve certain Vioxx-related claims involving plaintiffs who suffered a heart attack, including sudden cardiac death, or a stroke.

Hospira recalls saline injection due to human hair contamination

Recalls - Hospira-logo

Hospira Inc., is issuing a nationwide recall of one lot of 0.9 % Sodium Chloride Injection due to one confirmed report of human hair floating sealed in a bag of the solution in the additive port area. To date, there have been no adverse event reports associated with this issue. The recall affects one lot of 0.9 % Sodium Chloride Injection, USP, 250 mL (NDC 0409-7983-02, Lot 44-002-JT, Expiry 1AUG2016). Sodium Chloride is a saline solution used in catheter flush injections or intravenous infusions. Injected particulate material may cause adverse events such as local inflammation, phlebitis, and/or low-level allergic response. ... Read More

Outbreak of drug-resistant superbug linked to specialized endoscopes


A specialized endoscope, put into the throats of a half-million people each year to treat gallstones, cancers, and other digestive system problems, has been identified as the source of a deadly bacterial infection in patients who have undergone procedures using the devices. It was found that conventional methods of cleaning the specialized endoscopes, known as duodenoscopes, do not always remove the so-called superbug. If the bacteria is not thoroughly removed from the scopes, the devices can spread infections from patient to patient. The superbug, known as CRE, is highly resistant to numerous antibiotics and kills as many as 40 to 50 ... Read More

Coffee may help protect against deadly melanoma


People who drink four or more cups of coffee a day are 20 percent less likely to develop melanoma, the most deadly form of skin cancer, over 10 years, according to a new study published in the Journal of the National Cancer Institute. The benefit is only with caffeinated coffee and not decaf. The reason, researchers say, is that coffee contains numerous compounds that keep cancer-fighting processes that are triggered by UV light under control. The roasting process also causes coffee beans to release vitamin derivatives that have been shown to protect against UV damage in laboratory mice. There’s also some ... Read More

Long-term hormonal birth control use linked to rare brain tumors

mirena IUD

Women who use hormonal contraceptives for at least five years are at greater risk of developing a rare form of brain cancer known as glioma, a new study suggests. All forms of hormonal birth control contain estrogen, progestin or a combination of both hormones. These include birth control pills and patches, Mirena IUD, and NuvaRing. Gliomas are a very rare brain tumor with a very poor prognosis. Of the 10,000 patients diagnosed with malignant gliomas each year, only half are alive after one year, and only 25 percent survive two years. The study, published in the British Journal of Clinical ... Read More

FDA warns of serious injuries in pediatric patients treated with bone graft substitutes

child hospital patient - FDA image

Mounting reports of serious injuries in pediatric patients (younger than 18) who have received some types of bone graft substitutes have prompted the Food and Drug Administration (FDA) to issue a Safety Communication warning doctors that the safety and efficacy of these devices in pediatric patients has not been reviewed or approved and poses unique risks to patients younger than 18 years of age. The issue involves bone graft substitutes containing recombinant proteins or synthetic peptides, which have caused serious injuries in patients younger than 18 such as excess bone growth, fluid accumulation, inhibited bone healing, and swelling. While these events ... Read More

Isolation bags may lower cancer-spread risk with power morcellation but create new risks


Using isolation bags during power morcellation procedures is feasible and may help protect against the risk of cancer spread during minimally invasive gynecologic surgery, according to a study published in the journal Obstetrics & Gynecology. “Methods for morcellating uterine tissue in a contained manner may provide an option to minimize the risks of open power morcellation while preserving the benefits of minimally invasive surgery,” the study’s authors wrote. Power morcellation is a procedure using a surgical tool that minces uterine fibroids or entire uteruses inside the body and removes them through a small incision in the abdomen. The procedure has ... Read More

Most Medicare recipients not filling statin prescriptions after heart-related hospitalization


The majority of Medicare beneficiaries do not fill prescriptions for high-intensity statin drugs after being hospitalized for complications related to coronary heart disease, a new study has found. Researchers with the Icahn School of Medicine at Mount Sinai in New York City examined the proportion of Medicare recipients filing statin prescriptions after being discharged from the hospital for a cardiac event. They found that only 27 percent of first post-discharge prescription fills among 8,762 Medicare beneficiaries filling a statin prescription after a cardiovascular event were for a high-intensity statin. Cholesterol-lowering statins are prescribed to help prevent heart attacks and strokes ... Read More

Viagra could be key to treatments for other diseases


The erectile dysfunction drug Viagra could hold the key to new treatments for the flu, brain cancer, hepatitis, MRSA, and even the Ebola virus, according to a new study conducted at Virginia Commonwealth University. Viagra is in a class of drugs known as phosphodiesterase (PDE) 5A inhibitors, which work by attacking a protein known as GRP78. Researchers created a compound using Viagra and other drugs in the class such as Cialis. The compound, they discovered, prevented the replication of several different viruses in infected cells. They also made antibiotic-resistant bacteria vulnerable to common antibiotics, and defeated brain cancer stem cells. ... Read More

Fund requested to manage awards paid to women injured by transvaginal mesh

bladder sling

Women from more than 100 lawsuits in a multidistrict litigation (MDL) alleging injuries caused by Johnson & Johnson unit Mentor Corp.’s defective transvaginal mesh implant asked a Georgia federal judge this week to approve the establishment of a settlement fund trust to resolve their claims. The qualified settlement fund trust would hold, manage and distribute funds in the account under the settlements reached in April for 111 lawsuits in the multidistrict litigation. The trust would also cover additional lawsuits as they resolve. Both the settlements and the total amount in the trust are confidential. The lawsuits allege that Mentor Corp.’s ... Read More

In State of the Union address Obama vows to fund research to treat devastating diseases


President Obama in his State of the Union address vowed to fund more research into cures and treatments for devastating diseases including cancer and diabetes. “I want the country that eliminated polio and mapped the human genome to lead a new era of medicine – one that delivers the right treatment at the right time,” he said Tuesday night in his prepared remarks. The approach is known as the precision medicine initiative and is designed to deliver new and more effective treatments for diseases. While Obama offered only sparse details on the initiative and didn’t say how much it would ... Read More